Dangle
发表于 2025-3-21 18:43:19
书目名称Machine Learning in Medical Imaging影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0620679<br><br> <br><br>书目名称Machine Learning in Medical Imaging读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0620679<br><br> <br><br>
intercede
发表于 2025-3-21 23:28:20
Yongsong Huang,Qingzhong Wang,Shinichiro Omachi involve a surprisingly small set of conserved functions, most of which have been the focus of aging research for some time. For example, the mTOR pathway, a regulator of translation and protein synthesis, has been identified as a common longevity pathway in yeast and Caenorhabditis elegans. In mamm
jet-lag
发表于 2025-3-22 00:27:50
Xin You,Yun Gu,Junjun He,Hui Sun,Jie Yang involve a surprisingly small set of conserved functions, most of which have been the focus of aging research for some time. For example, the mTOR pathway, a regulator of translation and protein synthesis, has been identified as a common longevity pathway in yeast and Caenorhabditis elegans. In mamm
Ceremony
发表于 2025-3-22 05:22:59
Yunxiang Li,Ruilong Dan,Shuai Wang,Yifan Cao,Xiangde Luo,Chenghao Tan,Gangyong Jia,Huiyu Zhou,You Zh involve a surprisingly small set of conserved functions, most of which have been the focus of aging research for some time. For example, the mTOR pathway, a regulator of translation and protein synthesis, has been identified as a common longevity pathway in yeast and Caenorhabditis elegans. In mamm
狂热文化
发表于 2025-3-22 12:31:21
http://reply.papertrans.cn/63/6207/620679/620679_5.png
破布
发表于 2025-3-22 13:28:11
Ziang Xu,Sharib Ali,Soumya Gupta,Simon Leedham,James E. East,Jens Rittscher a progressive decline of global procoagulant factors and inhibitory coagulation parameters. At least by this stage, treatment should include the administration of antithrombin III (AT III) concentrates, dosed according to body weight, to maintain AT III activity at levels above 80% and thus reduce
和平
发表于 2025-3-22 18:57:26
Xi Chen,Jiahuan Lv,Dehua Feng,Xuanqin Mou,Ling Bai,Shu Zhang,Zhiguo Zhou a progressive decline of global procoagulant factors and inhibitory coagulation parameters. At least by this stage, treatment should include the administration of antithrombin III (AT III) concentrates, dosed according to body weight, to maintain AT III activity at levels above 80% and thus reduce
Arresting
发表于 2025-3-23 00:44:19
Loic Themyr,Clément Rambour,Nicolas Thome,Toby Collins,Alexandre Hostettler The greatest risk to patients is from new vascular occlusions..The principal antigen of type II HIT is a multimolecular complex composed of platelet factor 4 and heparin. The HIT antibodies bind to platelets and activate them via their Fc component and platelet Fc receptor II. HIT antibodies also b
overreach
发表于 2025-3-23 05:16:59
http://reply.papertrans.cn/63/6207/620679/620679_9.png
无表情
发表于 2025-3-23 06:52:59
Govind Jeevan,S. J. Pawan,Jeny Rajans for acquired disorders of coagulation have been developed and form a new basis for therapeutic strategies. Despite this progress, many physicians are aware of the problem that, especially for intensive care patients, a treatment very often has to be selected before diagnostic procedures can be completed. We978-3-540-61475-3978-3-642-60490-4